Furthermore, we demonstrate that FBXL10-PRC1 maintains the silencing of BCL6 target genes such as DUSP6 in DLBCL cells and therefore activates ERK1/2 to promote DLBCL cell proliferation. Here, MAPK3 is linked to diffuse large B-cell lymphoma.